C Labarre

795 total citations
30 papers, 640 citations indexed

About

C Labarre is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, C Labarre has authored 30 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Rheumatology and 9 papers in Immunology. Recurrent topics in C Labarre's work include Systemic Lupus Erythematosus Research (6 papers), Viral Infections and Immunology Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). C Labarre is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Viral Infections and Immunology Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). C Labarre collaborates with scholars based in France, Belgium and Poland. C Labarre's co-authors include Anne-Marie Quéro, Pascale Nicaise, Aude Gleizes, N. Verthier, Gérard Feldmann, F Forestier, E. Rogier, Olivier Meyer, Catherine Sandré and A. Rudent and has published in prestigious journals such as Journal of Nutrition, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

C Labarre

30 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Labarre France 14 199 156 124 96 88 30 640
Sabrina García de Aquino Brazil 18 301 1.5× 141 0.9× 166 1.3× 47 0.5× 122 1.4× 31 1.0k
Jeffrey C. Howard Canada 13 338 1.7× 130 0.8× 55 0.4× 103 1.1× 173 2.0× 20 765
Edward Collins United States 16 233 1.2× 126 0.8× 323 2.6× 113 1.2× 25 0.3× 26 1.1k
Martin Levine United States 20 378 1.9× 59 0.4× 154 1.2× 78 0.8× 50 0.6× 52 1.4k
Jacek Szeliga Poland 18 157 0.8× 70 0.4× 304 2.5× 82 0.9× 31 0.4× 51 1.1k
Izabel Galhardo Demarchi Brazil 17 127 0.6× 37 0.2× 87 0.7× 158 1.6× 100 1.1× 52 913
Haruna Miyazawa Japan 14 369 1.9× 46 0.3× 93 0.8× 130 1.4× 57 0.6× 30 963
S Nagao Japan 15 249 1.3× 32 0.2× 515 4.2× 185 1.9× 40 0.5× 29 1.0k
Amir Hossein Siadat Iran 17 52 0.3× 94 0.6× 73 0.6× 175 1.8× 56 0.6× 83 903
Tsuneyuki Ubagai Japan 22 558 2.8× 269 1.7× 195 1.6× 105 1.1× 38 0.4× 50 1.3k

Countries citing papers authored by C Labarre

Since Specialization
Citations

This map shows the geographic impact of C Labarre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Labarre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Labarre more than expected).

Fields of papers citing papers by C Labarre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Labarre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Labarre. The network helps show where C Labarre may publish in the future.

Co-authorship network of co-authors of C Labarre

This figure shows the co-authorship network connecting the top 25 collaborators of C Labarre. A scholar is included among the top collaborators of C Labarre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Labarre. C Labarre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Olivier, P. Nicaise‐Roland, C Labarre, et al.. (2006). Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Research & Therapy. 8(2). R40–R40. 71 indexed citations
2.
Grootenboer‐Mignot, S., et al.. (2004). Second generation anti‐cyclic citrullinated peptide (anti‐CCP2) antibodies can replace other anti‐filaggrin antibodies and improve rheumatoid arthritis diagnosis. Scandinavian Journal of Rheumatology. 33(4). 218–220. 17 indexed citations
3.
Sandré, Catherine, Aude Gleizes, F Forestier, et al.. (2001). A Peptide Derived from Bovine β-Casein Modulates Functional Properties of Bone Marrow-Derived Macrophages from Germfree and Human Flora-Associated Mice. Journal of Nutrition. 131(11). 2936–2942. 75 indexed citations
5.
Meyer, Oliver, Pascale Nicaise, Stéphane Moreau, et al.. (1996). Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.. PubMed. 63(4). 241–7. 9 indexed citations
6.
Nicaise, Pascale, et al.. (1995). The influence ofE. coliimplantation in axenic mice on cytokine production by peritoneal and bone marrow-derived macrophages. Cytokine. 7(7). 713–719. 13 indexed citations
7.
Meyer, Olivier, et al.. (1995). Heart valve disease in systemic lupus erythematosus. Clinical Reviews in Allergy & Immunology. 13(1). 49–56. 7 indexed citations
8.
Guillemard, Eric, Monique Geniteau‐Legendre, G. Lemaire, et al.. (1995). Role of trehalose dimycolate-induced interferon-α/β in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures. Antiviral Research. 28(2). 175–189. 8 indexed citations
9.
Crickx, B., et al.. (1995). [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].. PubMed. 122(10). 667–70. 3 indexed citations
10.
Guillemard, Eric, Monique Geniteau‐Legendre, I. Poîlane, et al.. (1993). Antiviral action of trehalose dimycolate against EMC virus: role of macrophages and interferon α/β. Antiviral Research. 22(2-3). 201–213. 11 indexed citations
11.
Quéro, Anne-Marie, et al.. (1992). Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages. Journal of Antimicrobial Chemotherapy. 30(2). 173–179. 44 indexed citations
12.
Rudent, A., et al.. (1990). Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. Journal of General Virology. 71(2). 477–479. 60 indexed citations
13.
Rogier, E., et al.. (1989). Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: Morphology and immunocytochemical studies of hepatic-secreted proteins. In Vitro Cellular & Developmental Biology - Plant. 25(3). 267–275. 103 indexed citations
14.
Séta, Nathalie, et al.. (1988). Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers. Clinical Pharmacology & Therapeutics. 44(4). 458–466. 21 indexed citations
15.
Michel, Frédérique, et al.. (1987). Effects of RU 41740 aerosol treatment on mouse bronchoalveolar cells, and protection afforded against influenza virus infection. International Journal of Immunopharmacology. 9(7). 775–781. 8 indexed citations
16.
Chavance, M., C Labarre, A Jacqueson, et al.. (1986). Thyroxine-binding prealbumin, overnutrition and apolipoprotein A1.. PubMed. 40(5). 359–64. 4 indexed citations
17.
Rudent, A., et al.. (1985). Effect of RU 41740 on polymorphonuclear leukocytes chemotaxis. International Journal of Immunopharmacology. 7(3). 365–365. 2 indexed citations
18.
Wade, Salimata, et al.. (1985). Variations in plasma thyroxine-binding prealbumin (TBPA) in relation to other circulating proteins in post-operative patients during rapid oral refeeding.. PubMed. 39(1). 55–62. 10 indexed citations
19.
Michel, Frédérique, et al.. (1985). Effect of RU 41740 on chemiluminescence production by mice alveolar macrophages. International Journal of Immunopharmacology. 7(3). 365–365. 3 indexed citations
20.
Labarre, C, et al.. (1977). [Anti-aspirin antibodies elicited in the rabbit after immunization with various aspirin-protein conjugates].. PubMed. 35(7-8). 257–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026